Esther Szu-Chia Shao, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Activin Receptors, Type II | 4 | 2009 | 127 | 0.540 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.310 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 644 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2009 | 3510 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2009 | 162 | 0.120 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2008 | 838 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 12066 | 0.110 |
Why?
|
| Activin Receptors, Type I | 2 | 2008 | 142 | 0.100 |
Why?
|
| Cattle | 4 | 2009 | 3917 | 0.090 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2009 | 29 | 0.090 |
Why?
|
| Growth Differentiation Factors | 1 | 2009 | 98 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2008 | 850 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 3 | 2008 | 1081 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2009 | 3482 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 640 | 0.060 |
Why?
|
| Mesoderm | 1 | 2006 | 686 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3701 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 3504 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 688 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2009 | 19232 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3106 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2006 | 349 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 4459 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 2006 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2008 | 281 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40038 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6485 | 0.020 |
Why?
|
| Animals | 4 | 2009 | 168660 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 906 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 913 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1683 | 0.010 |
Why?
|
| Plasmids | 1 | 2006 | 2308 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4749 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 2062 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5892 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12798 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5867 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9731 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2008 | 23398 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11360 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2008 | 3445 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15993 | 0.010 |
Why?
|
| Humans | 4 | 2009 | 743811 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10477 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 21824 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11478 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 81154 | 0.000 |
Why?
|